Loading...
XSTO
CARA
, Last price  
SEK
Name

Carasent AB (publ)

Chart & performance

D1W1MN
XSTO:CARA chart
P/E
—
P/S
—
EPS
0.48
Vol. 1Y
—
Shs. 5Y
9.09%
Rev. 5Y
37.26%
Div Yld LY
—
Div Yld TTM
—
Revenues
344m
+28.82%
133,328,000210,380,000234,035,000250,429,000227,161,000242,775,000239,406,000254,181,000294,212,749302,532,000193,759,000023,965,00047,927,00070,576,000137,125,000195,259,000243,984,000266,895,974343,820,000
Net income
35m
P
-37,226,000-138,521,000-57,573,000-20,429,000-18,283,0004,196,0007,063,0004,750,000-79,228,00060,232,000141,793,00020,307,000-7,034,0003,212,000-38,131,000-148,00031,170,000-46,445,000-40,974,32634,670,000
CFO
40m
+10.54%
-9,430,000-23,211,000-11,714,00010,643,0007,195,77322,162,15432,287,41429,076,22524,081,4140-35,589,571089,00012,045,00018,761,00032,480,00033,612,000-4,467,00036,578,16040,435,000
Dividend
Nov 15, 20231.84 SEK/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webcur, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient communication and business intelligence. The company was founded in 1997 and is headquartered in Gothenburg, Sweden.
IPO date
Dec 09, 2024
Employees
Domiciled in
SE
Incorporated in
SE
Headquarters & legal address
Nellickevägen 20
Göteborg, O 412 63
SE
Address
Nellickevagen 20
Goteborg, O 412 63
SE

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT